GSK Investigational Site

Catanzaro 88100

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Respiratory Syncytial Virus Infections

Studies at this site

• Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) — Running, not enrolling
• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed